Epilepsy Adult & adolescent ≥13 yr Monotherapy 25 mg once daily in wk 1 & 2, followed by 50 mg once daily in wk 3 & 4. Maintenance: 100-200 mg once daily or in 2 divided doses, may be increased by max 50-100 mg every 1-2 wk.
Adjunctive therapy w/ valproate 25 mg given on alternate days in wk 1 & 2, followed by 25 mg once daily in wk 3 & 4. Maintenance: 100-200 mg once daily or in 2 divided doses, may be increased by max 25-50 mg every 1-2 wk.
Adjunctive therapy w/o valproate & w/ inducers of lamotrigine glucuronidation 50 mg once daily in wk 1 & 2, followed by 100 mg/day in 2 divided doses in wk 3 & 4. Maintenance: 200-400 mg/day in 2 divided doses, may be increased by max 100 mg every 1-2 wk.
Adjunctive therapy w/o valproate & w/o inducers of lamotrigine glucuronidation 25 mg once daily in wk 1 & 2, followed by 50 mg once daily in wk 3 & 4. Maintenance: 100-200 mg once daily or in 2 divided doses, may be increased by max 50-100 mg every 1-2 wk.
Childn & adolescent 2-12 yr Monotherapy of typical absence seizures 0.3 mg/kg/day once daily or in 2 divided doses in wk 1 & 2, followed by 0.6 mg/kg/day once daily or in 2 divided doses in wk 3 & 4. Maintenance: 1-15 mg/kg/day once daily or in 2 divided doses, may be increased by max 0.6 mg/kg/day every 1-2 wk. Max: 200 mg/day.
Adjunctive therapy w/ valproate 0.15 mg/kg once daily in wk 1 & 2, followed by 0.3 mg/kg once daily in wk 3 & 4. Maintenance: 1-5 mg/kg/day once daily or in 2 divided doses, may be increased by max 0.3 mg/kg every 1-2 wk. Max: 200 mg/day.
Adjunctive therapy w/o valproate & w/ inducers of lamotrigine glucuronidation 0.6 mg/kg/day in 2 divided doses in wk 1 & 2, followed by 1.2 mg/kg/day in 2 divided doses in wk 3 & 4. Maintenance: 5-15 mg/kg/day once daily or 2 divided doses, may be increased by max 1.2 mg/kg every 1-2 wk. Max: 400 mg/day.
Adjunctive therapy w/o valproate & w/o inducers of lamotrigine glucuronidation 0.3 mg/kg/day once daily or in 2 divided doses in wk 1 & 2, followed by 0.6 mg/kg/day once daily or in 2 divided doses in wk 3 & 4. Maintenance: 1-10 mg/kg/day once daily or in 2 divided doses, may be increased by max 0.6 mg/kg every 1-2 wk. Max: 200 mg/day.
Bipolar disorder Adult ≥18 yr Recommended dose escalation to the maintenance total daily stabilisation dose:
Monotherapy or adjunctive therapy w/o valproate & w/o inducers of lamotrigine glucuronidation 25 mg once daily in wk 1 & 2, followed by 50 mg once daily or in 2 divided doses in wk 3 & 4, then 100 mg once daily or in 2 divided doses in wk 5. Usual target stabilisation dose: 200 mg once daily or in 2 divided doses.
Adjunctive therapy w/ valproate 25 mg given on alternate days in wk 1 & 2, followed by 25 mg once daily in wk 3 & 4, then 50 mg once daily or in 2 divided doses in wk 5. Usual target stabilisation dose: 100 mg once daily or in 2 divided doses. Max: 200 mg daily.
Adjunct therapy w/o valproate & w/ inducers of lamotrigine glucuronidation 50 mg once daily in wk 1 & 2, followed by 100 mg/day in 2 divided doses in wk 3 & 4, then 200 mg/day in 2 divided doses in wk 5. Usual target stabilisation dose: 300 mg/day in 2 divided doses in wk 6, increasing to 400 mg/day in 2 divided doses in wk 7 if necessary.